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We demonstrated in 2011 that 61% of men with postoperative PSA failure had some cribriform pattern of prostate cancer, versus
16% of nonfailures (OR = 5.89, P<. 0001). That study used digitized radical prostatectomy slides from 153 men, 76 failures
(≥0.2ng/mL) matched to 77 nonfailures. The current study’s hypothesis: pseudolumen size and shape variability could stratify
outcome within histologic patterns (single separate acini, separate acini with undulating lumens, fused small acini, papillary,
cribriform). Pseudolumens were ﬁlled digitally on image captures from previously annotated specimens. Among all 5 patterns,
pseudolumen spaces averaged smaller in failures than nonfailures. After multivariate analysis controlling for stage, age, margin,
cancer amount, prostate volume, and presence of individual cells (grade 5), this retained signiﬁcance only for the undulating-
lumens and papillary patterns. In undulating-lumens pattern, PSA failures had smaller mean pseudolumen space sizes (P = .03)
but larger perimeters (P = .04), implying more pseudolumen irregularity. In papillary pattern, the number of pseudolumen spaces
was higher in failures (P = .015), space size was smaller (P = .11), perimeters were smaller (P = .04), and perimeter/size ratio was
higher (P = .02). In conclusion, digitally measured pseudolumen size and shape may associate with outcome.
1.Introduction
In1966,a5-tierprostatecancergradingsystemthatreliesen-
tirely on architectural features was devised by Donald Glea-
son, who correlated patient outcome with the histologic pat-
terns in 270 Veterans Administration patients [1]. The Glea-
son system is now recognized to predict pathologic stage and
guides treatment choice. A few reﬁnements have been intro-
duced to the grading system, some by Gleason himself [2, 3].
Grades of 1 and 2, the lowest grades, have fallen into clinical
irrelevance [4, 5], and grade 5 is fairly rare, and thus most
cancers are grade 3, grade 4, or a combination of the two,
creating three usual diagnostic bins. Gleason later designated
a large acinar, undulating pattern of separate acini as pattern
3A and cribriform/papillary carcinoma as pattern 3C [3].
Cribriform cancer in 2000 was still deemed grade 3 [6], but
the grading of cribriform cancer later became controversial
[3, 7–10].
Withinanypatternofcancer,thereisacontinuumofsize,
shape, and spacing of pseudolumens. The current work aims
todiscoverwhethertheserelativediﬀerencesinpseudolumen
morphology for any histologic pattern can substratify its as-
sociation with outcome. We addressed this question by cap-
turing images within a set of 153 previously scanned and an-
notated specimens [11], then annotating and analyzing the
number, size, and shape of pseudolumens. Moreover, in our
recent study, within the continuum of histologic patterns
considered grade 4, the cribriform pattern was associated
with a distinctly adverse outcome [11]. In the prostate cancer
population that was studied, the frequency of any cribriform
cancer was 38% of specimens: a higher frequency than
the frequency of 23% for individual cells, the prototypical2 Prostate Cancer
Gleason grade 5. Yet, PSA failure was even more strongly as-
sociated with presence of cribriform pattern than with pre-
sence of individual cell pattern; thus, the current study paid
special attention to cribriform pattern.
2.MaterialsandMethods
The study used the set of slides from 153 cases of prostate
cancer that we published previously [11]. Men chosen for
the study came from 3 medical centers: the University of
Colorado Denver Hospital (n = 44), University of Wis-
consin Health System (n = 60), and Methodist Hospital,
Houston (n = 49).Exclusioncriteria wereahistoryofreceiv-
ing cryotherapy, radiotherapy, or androgen deprivation be-
fore failure. All men had postoperative drops in PSA to
undetectable. Most had Gleason score 7 cancer (95% in the
6–8 range). Biochemical failure was considered as a rise to
≥0.2ng/mL, without evidence of later, lower measurements
that would invalidate the 0.2. All but 2 nonfailures had at
least2years’followup;2hadbetween1and2years’followup.
At all contributing sites, prostates were completely sampled
at 4–6mm intervals.
2.1. Histologic Pattern and Pseudolumen Annotation. Pa-
tients’ entire prostatectomy slide sets had been re-reviewed.
Those slides containing cancer (average per case, 8.0 ± 4.3)
were digitally scanned as virtual slides using an Aperio Scan-
Scope XT at a resolution of 0.50um/pixel (Aperio Technol-
ogies, Vista, Calif) [11]. Using Image Scope software, all foci
of 6 histologic patterns were previously manually annotated
in a nonoverlapping manner, using a diﬀerent color for each
pattern, denoted as follow: (1) S: single, separate small acini
like 3B pattern [3]; (2) U: undulated, stellate, or branching
medium acini, like 3A pattern [3]; (3) F: fused, ragged small
acini including those with mucin; (4) P: (micro)papillary
consisting of medium to large spaces with either stromal
cores or strands of cells with one or more cell layers bridging
across the acinus, with intervening slit-like spaces; (5) C: cri-
briform, with medium to large acinar spaces having pun-
ched-out lumens (inclusive of the glomeruloid pattern [12]);
(6) I: individual inﬁltrating or sheet-like cells lacking lumen
formation. For each specimen, a representative 1500 × 1000
pixel section was captured from each annotated pattern
(excluding I pattern, since it lacks lumens). All pseudolumen
spaces in each image were further annotated using Photo-
shop. Annotated pseudolumen spaces were then analyzed for
several diﬀerent morphometric criteria using a custom writ-
ten ImageJ plugin. Measurements for pseudolumen object
frequency, area, circularity, perimeter, and maximum and
minimum feret diameter were recorded and formatted for
subsequent analysis.
Subsequent analysis was focused on the 48 specimens
with cribriform pattern, of which 37 had PSA failure, com-
pared to 9 without failure. For each, a second 1500 × 1000
pixel ImageScope snapshot was taken from cribriform areas,
using cribriform foci from diﬀerent slides than previous or
diﬀerent foci from the same slide, wherever possible (n =
43). In 5 cases the small size of the cribriform area precluded
capturing two snapshots without overlap, so analysis was
based on one snapshot. Pseudolumen space annotation and
analysis were carried out as above.
2.2. Statistical Analysis. For each patient, biochemical failure
statuswasrecorded.Todeterminewhetherfailurewasrelated
to any measurement for the patterns or to preoperative se-
rum PSA, pathologic stage, grade, and margin status (but
not Gleason score, owing to collinearity with the measured
data), univariate and multivariate analyses were used. Only
multivariate analysis results are displayed.
Depending on the distribution of the underlying data, ei-
ther parametric or nonparametric tests were used to deter-
mine the associations of biochemical failure with clinical and
pathologic parameters. Logistic regression analysis was used
to test associations with failure while adjusting for potential
confounding variables. All tests were two-sided, and signiﬁ-
cance level was set at P<. 05. All analyses used SAS version
9.2 (SAS Institute, Cary, NC).
3. Results
The cases and controls were matched on length of follow-
up, age at surgery, stage, and grade. Clinicopathologic data
on their specimens, from which 1,100 slides were digitized
and annotated, proved that a successful match was made
on age and length of followup [11]. With our limited num-
ber of possible controls, however, stage and grade were not
completely matched. To account for any mismatching, we
adjusted our multivariate models for these potential con-
founders. Because we did match, or attempted to match on
age, stage, grade, and length of followup, the independent
relationship of these variables to PSA failure could not be
assessed, as the distribution of these variables in controls did
not represent a random sample.
By our deﬁnition of PSA failure, the 153 total patients
comprised76(49.7%)withPSAfailureand77(50.3%)with-
out failure. Five had known metastases, and 6 had prostatic
fossa recurrence. There were 5 deaths from prostate cancer
(3.3%) and 2 from other causes in the study. As expected,
patientage,follow-updays,andprostatevolumeweresimilar
with respect to PSA failure status. 105 (68.6%) specimens
were Gleason ≥7, 67 (43.8%) were stage T3, and 51 (33.3%)
specimens had positive margins. Table 1 demonstrates that
there were signiﬁcant diﬀerences between the failures and
nonfailures for many measurements for single separate acini,
separateaciniwithundulatinglumens,fusedsmallacini,and
papillary acini. As a general trend across all patterns, the
mean pseudolumen space size was smaller in failures than in
nonfailures. These diﬀerences were adjusted by multivariate
analysis for preoperative serum PSA, pathologic stage, grade,
andmarginstatus,andthepresenceoftheindividualcellpat-
tern (I) which by deﬁnition had to be a categorical variable
due to having no annotatable lumens. Signiﬁcance for odds
ratiosoffailurepersistedfortheundulating-lumensandpap-
illary patterns. In the undulating-lumens pattern (Figure 1),
PSAfailureshadsmallermeanpseudolumenspacesizes(P =
.03) but larger pseudolumen perimeters (P = .04), implyingProstate Cancer 3
Table 1: Pseudolumen measurements according to pattern, other than cribriform.
Histologic pattern Nonfailures Failures Median for
nonfailure
Median for
failure
P value,
Wilcoxon
Rank Sum
Odds ratio,
adjusted∗
P value for
odds ratio
Single separate acini n = 80 n = 68
No. of pseudolumen spaces 39.5 42.9 .49 0.997 .79
Size of spaces based on mean, µm2 160 130 .03 0.998 .16
Perimeter of spaces, µm 233 204 .004 0.996 .09
Perimeter/size ratio 1.49 1.58 .17 1.29 .49
Undulating-lumen separate acini n = 61 n = 50
No. of pseudolumen spaces 34.0 30.5 .23 0.971 .06
Size of spaces based on mean, µm2 342.9 314.5 .77 1.001 .03
Perimeter of spaces, µm 363 416 .69 1.002 .04
Perimeter/size ratio 1.19 1.21 .89 0.576 .39
Fused small acini: n = 62 n = 62
No. of pseudolumen spaces 47.5 46.5 .75 0.975 .98
Size of spaces based on mean, µm2 66.5 49.1 .002 0.066 .07
Perimeter of spaces, µm 147 117 .002 0.153 .15
Perimeter/size ratio 2.21 2.46 .003 0.059 .06
True papillary acini n = 31 n = 43
No. of pseudolumen spaces 28.0 43.0 .008 1.05 .015
Size of spaces based on mean, µm2 355.7 190.8 .025 0.99 .11
Perimeter of spaces, µm 382 262 .023 0.997 .04
Perimeter/size ratio 1.16 1.46 .061 4.77 .02
∗By multivariate analysis adjusting for preoperative serum PSA, pathologic stage, grade, margin status, and the presence of the individual cell pattern.
Table 2: Pseudolumen measurements for the cribriform pattern.
Cribriform acini Median for
nonfailure, n = 9
Median for failure,
n = 39
P value, Wilcoxon
Rank Sum
Odds ratio,
adjusted∗
P value for
odds ratio
No. of pseudolumen spaces 37 48 .552 1.022 .394
Size of spaces based on mean, µm2 133.5 96.0 .125 0.987 .048
Perimeter of spaces, µm 206.2 167.5 .125 0.987 .070
Perimeter/size ratio 1.41 1.75 .178 7.076 .074
∗By multivariate analysis adjusting for preoperative serum PSA, pathologic stage, grade, margin status, and the presence of the individual cell pattern.
more irregularity of the spaces. In the true papillary pattern
(Figure 2), the number of pseudolumen spaces was higher in
failures (P = .015), the size of spaces was smaller (P = .11),
the perimeter of spaces was smaller (P = .04), and the pe-
rimeter/sizeratiowashigher(P = .02).Thelatterresultagain
implies more irregularity of the spaces. These both stand
in contrast to benign acini, which have large, open lumens
(Figure 3).
For the cribriform pattern, some correlations based on
one image capture per specimen were signiﬁcant, and since
our prior work had shown that the cribriform pattern carries
the most adverse prognosis of all patterns examined [11],
we chose to expand the data by capturing a second set of
nonoverlapping cribriform cancer images from a diﬀerent
slide where possible. Notably, no specimen had any necrosis
withinthecribriformcomponentandnoneofthecribriform
areas ﬁt the criteria for ductal carcinoma morphology [13–
15]. In Table 2, the median of pseudolumen space size was
smaller (133.5) in the failures compared to the failures (96.1)
(P = .048). The median perimeter of pseudolumens was
167.5 in the failures versus 206.2 in nonfailures (P = .070).
However, the perimeter/size ratio, describing the degree of
lumen contour irregularity, was 1.75 in the failures, higher
than the 1.41 in nonfailures (P = .074).
The individual cell (I)/Gleason 5 pattern was seen in 35
patients (23%) and in 13 (27%) of 48 specimens with cri-
briform pattern, all but one of which belonged to a man
with PSA failure. A previous study had shown that C pattern
frequently coexisted with I pattern, and these were multi-
plicative with regard to odds ratio for failure and probably
minimized the independent associative value for the fairly
rareIpattern[11].Multivariateanalysis,asabove,considered
the presence of I pattern. Size of pseudolumens retained
signiﬁcance (P = .040), and perimeter had borderline signif-
icance (P = .058). An increased perimeter/size ratio gave a
high OR for failure, but this missed signiﬁcance.4 Prostate Cancer
Figure 1: Image capture of undulating lumens grade 3 pattern,
1500 × 1000 pixels, after pseudolumen annotation. Lumens are
very irregular; there is perineural invasion. Patient had PSA failure
(100x).
Figure 2: Image capture of true papillary grade 4 pattern, 1500 ×
1000 pixels, after pseudolumen annotation. Note bridging across
gland space. Patient had PSA failure (100x).
4. Discussion
Large acinar (LA) prostate cancer, comprising the cribriform
(C) and papillary (P) patterns, is associated with higher PSA
failure odds ratios than other high-grade patterns [11]. Here
we have shown, ﬁrstly, that there was a trend toward smaller
lumen sizes in all 5 patterns. After adjusting for other clini-
copathologic ﬁndings by multivariate analysis, this held sig-
niﬁcance for separate, medium-sized glands with undulating
lumens and for the P pattern. For the undulating-lumens
Figure 3: Benign prostatic acini can have undulating, or papillary
lumens have lumens that are large and open, usually without bridg-
ing across the gland space except in the central zone. Pseudolumen
spaces in cancer show various degrees of deviation from normal
(100x).
pattern, larger perimeter of the gland spaces was noted in
men with PSA failure, suggesting that a greater complexity
of infoldings in this Gleason grade 3 pattern correlates with
advanced tumor development. Moreover, within the grade 4,
P pattern, there were signiﬁcant trends for increased num-
ber, smaller size, and greater irregularity (perimeter/size ra-
tio) of pseudolumen spaces to be associated with PSA fail-
ure. This suggests that, as its epithelium assumes a more
complex, nearly solid pattern, there is more advanced tumor
development. Finally, the number of men with C pattern was
too small of a sample set, with only 9 of 48 men without fail-
ure, precluding much statistical signiﬁcance for its pseudol-
umen ﬁndings, but further study is warranted.
Cribriform and papillary (LA) cancers, as recently as
2000, were placed under grade 3 by a consensus statement
of the College of American Pathologists [6]. Subsequent
evidence for an elevated biologic potential of cribriform
cancer came from Kronz et al., who, in their biopsy study of
“atypical cribriform lesions,” found that 55% of patients had
cancer on repeat biopsy. Also, of 10 patients with subsequent
carcinoma, 6 had a component of Gleason pattern 4 [9]. The
InternationalSocietyofUrologicalPathology(ISUP)grading
consensus conference of 2005 judged that most cribriform
structures were grade 4, but those that were rounded and of
comparable size to benign acini could be graded as grade
3[ 7]. Cribriform pattern (small or large) was present in
60.5% of men with PSA failure but only 15.6% of matched
men without failure, resulting in an odds ratio (OR) for PSA
failure of 5.89, higher than for any other pattern. The ad-
verse implications of cribriform pattern presence did not de-
pendonwhetherthecribriformareawaslargeandsprawling,
or small, round, and circumscribed. Papillary (P) pattern,
the other LA pattern, had a somewhat lower but signiﬁcantProstate Cancer 5
2.155 odds ratio for PSA failure [11]. Strikingly, among 17
cases with a preponderance of LA (cribriform and papillary)
patterns amounting to 1/3 of cancer area, the odds ratio for
failure reached 10.80. The ability of pseudolumen measure-
ments to further stratify outcome within LA cancer warrants
further investigation.
The only other digital analysis of the correlation of mor-
phometric imaging features with clinical failure was that of
Donovan et al. from Aureon Laboratories [16]. That study
used a model that incorporated the spacing between epithe-
lial tumor cells and the ratio of epithelial tumor cell area
to total tumor area, in grade 3 cancer in prostatic needle
biopsies.Combinedwiththesemorphologicdatawerequan-
titativemultipleximmunoﬂuorescenceresultsandthreeclin-
icopathologic features. The current study, in contrast, as-
sessed ﬁve pseudolumen-forming patterns identiﬁable in
grades 3 and 4 cancer and indirectly approximated the per-
cent of epithelium present by measuring the proportion of
pseudolumen area in standard size images, as well as the
shapes of those spaces. An asset of this approach is cost-ef-
fective outcomeprediction without the need for immunoﬂu-
orescence. A limitation was the inability to mark epithelium
diﬀerentlyfromstroma(whichmightbedoneinfuturestud-
ies using a reticulum stain, a technique that may have sharp-
ened the discrimination of the observed associations).
Because of several other limitations of the current study,
validation studies using unselected cases will be needed be-
fore results are applied to the population of prostate cancer
patients diagnosed on biopsy. The ﬁrst limitation was that
PSA failures were enriched. Since failure is a rarer outcome
than nonfailure, it was necessary to overrepresent failures in
thematchingprocesstotryforstatisticalsigniﬁcance.Match-
ing the nonfailures for stage, grade, and margins also skew-
ed the nonfailure population to those with more adverse fea-
tures. Second, the use of prostatectomy specimens was se-
lected for those men who chose surgery and who probably
had more aggressive cancer than average. This too was nec-
essary, in order to quantify the entire cancer in the gland
without the sampling error inherent in biopsies. A prospec-
tive study on biopsy material would be needed to represent
the entire spectrum of men with cancer, some of whom elect
watchful waiting, hormone ablation, radiation, or cryother-
apy. Hence, this study’s ﬁndings apply best to men who are
surgical candidates. Finally, using PSA failure is a valid end-
point, but less deﬁnite than death from cancer; however, the
study would have had to include many more men to amass a
suﬃcient number of deaths.
5. Conclusion
Morphometry of the pseudolumens of certain acinar pat-
terns—separate acini with undulating lumens, papillary, and
cribriform—may correlate with biochemical failure in pros-
tatecancer.Somelimitationsofthisstudyrendertheseresults
preliminary, but future studies should use an unselected
population to examine the relationship of lumen size, shape,
and spacing within annotated patterns to outcome.
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